Support for smart combinations and converging regulations.
Six fundamental types of drug-device combinations illustrate how digital tools can enhance pharmaceutical treatments.
- Support: Focuses on adherence and managing side effects and ensuring overall patient well-being during the primary treatment.
- Priming: Administering treatments beforehand to induce protective adaptations.
- Maintenance: Continuous treatment aimed at preventing disease recurrence or maintaining remission after initial success.
- Adjacent: Treatment given alongside the primary therapy for a complementary effect.
- Concurrent: Multiple treatments administered simultaneously to create a synergistic effect.
- Chronotherapy: Treatment timed to align with the body’s natural rhythms, enhancing effectiveness and reducing side effects.
Aligning with PDURS
We guide digital health companies navigating the overlap of drugs, devices, and software. Whether aligning with PDURS in the U.S. or leveraging DiGA’s upcoming Class IIb device expansion, we help you plan integrated regulatory strategies.
